"End Stage Liver Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
| Descriptor ID |
D058625
|
| MeSH Number(s) |
C06.552.308.500.177
|
| Concept/Terms |
Chronic Liver Failure- Chronic Liver Failure
- Chronic Liver Failures
- Failure, Chronic Liver
- Failures, Chronic Liver
- Liver Failures, Chronic
- Liver Failure, Chronic
|
Below are MeSH descriptors whose meaning is more general than "End Stage Liver Disease".
Below are MeSH descriptors whose meaning is more specific than "End Stage Liver Disease".
This graph shows the total number of publications written about "End Stage Liver Disease" by people in this website by year, and whether "End Stage Liver Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 4 | 0 | 4 |
| 2012 | 5 | 2 | 7 |
| 2013 | 5 | 1 | 6 |
| 2014 | 4 | 0 | 4 |
| 2015 | 5 | 0 | 5 |
| 2016 | 6 | 2 | 8 |
| 2017 | 7 | 2 | 9 |
| 2018 | 10 | 1 | 11 |
| 2019 | 9 | 2 | 11 |
| 2020 | 11 | 3 | 14 |
| 2021 | 8 | 1 | 9 |
| 2022 | 4 | 0 | 4 |
| 2023 | 6 | 0 | 6 |
| 2024 | 2 | 8 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "End Stage Liver Disease" by people in Profiles.
-
Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study. Clin Transplant. 2024 Dec; 38(12):e70034.
-
Constructing an Intent-to-Treat Score Index to Predict Survival Outcomes in Pediatric Liver Transplant Recipients. Pediatr Transplant. 2024 Aug; 28(5):e14816.
-
Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium. Liver Transpl. 2024 Nov 01; 30(11):1106-1115.
-
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis. Liver Transpl. 2025 Jan 01; 31(1):24-31.
-
Unseen foe: The financial toxicity of liver transplantation. Liver Transpl. 2024 Sep 01; 30(9):873-874.
-
Controversies in terlipressin and transplantation in the United States: How do we MELD the two? Liver Transpl. 2024 Jul 01; 30(7):753-759.
-
Identifying drivers of cost in pediatric liver transplantation. Liver Transpl. 2024 Aug 01; 30(8):796-804.
-
Effect of a Hispanic outreach program on referral and liver transplantation volume at a single center. Transpl Immunol. 2024 Jun; 84:102034.
-
Optimization of Kidney Health in Liver Transplant Candidates: Pretransplant Considerations and Modalities. Transplantation. 2024 Jul 01; 108(7):1542-1550.
-
Retrospective Analysis of the Impact of High- and Low-Quality Donor Livers for Patients with?High-Acuity Illness. Ann Transplant. 2024 Jan 09; 29:e941931.